NCI Director Highlights Progress, Challenges in Cancer Research

Last week, the National Institutes of Health (NCI) of the National Institute of Health (NIH) published an annual report on cancer status in 2018. At the opening meeting on 2nd June, NCI Director Norman E. Sharpless, MD highlighted the best news reported to the participants of the annual meeting. Country of Citizenship

However, Dr. Sharpless also brought in other good news: "We received strong and bipartisan support from cancer from the Congress," the budget of NCI and NIH will increase for four consecutive years did. The comprehensive budget that Congress passed has brought about $ 275 million in growth to the NCI budget this year and he also offered total funds for cancer Moonshot, he said.

With improved survival, successful treatment, and ongoing support for research, there is a good reason to maintain an optimistic view of the oncology community. "I think that groundbreaking possibilities have grown unprecedented," he stated.

At the same time, there are major challenges, including certain cancers such as glioblastoma that are still resistant to treatment work, and toxicity associated with certain treatments. Treatment of complications for appreciation, "There is a possibility that it is obviously catastrophic for cancer survivors."

Dr. Sharpless identified four areas that NCI wanted to focus on while he was in office.

Regarding the first focus of fundamental science support, Dr. Sharpless announced that it allocated an additional $ 227 million this year for research project funds for research-led scientific research. The news received a strong applause

"Cancer of war" is also bad as well. John Bailar III should know about cancer. He works at the National Cancer Institute (NCI), a statistical consultant at NCI Jorunal, the New England Medical Journal, and a lecturer at Harvard Public Health Graduate School. He began to doubt the effectiveness of the entire cancer research program in the 1970's and left NCI in 1980. At the New England Journal of Medicine in 1986, he wrote an article titled "Cancer Progress". From 1950 to 1982, there was no evidence that medical advances delayed cancer and cancer mortality. If anything, the situation is getting worse than before.

Last week, the National Institutes of Health (NCI) of the National Institute of Health (NIH) published an annual report on cancer status in 2018. At the opening meeting on 2nd June, NCI Director Norman E. Sharpless, MD highlighted the best news reported to the participants of the annual meeting. Nationality However, Dr. Sharpless also brought other good news: "We received strong and bipartisan support from the Congress on cancer research," the budget of NCI and NIH increased for 4 consecutive years Did. He said that the comprehensive budget passed by Congress provided growth of $ 275 million for the NCI budget this year and total funds for cancer Moonshot.